InsiderClue
← All stocks

Monopar Therapeutics

MNPR Net selling
CIK 0001645469 #2760 in the set updated 18 Sep 2026
Bought (120 mo)
$6.28M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$40.85M
$806.76K on a plan · $1.70M straight out of an exercise
Sold at will
$38.34M
9 of 22 sales
Net
−$34.56M
−$32.06M against sales at will

By person

15 insiders · 44 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Tactic Pharma LLC entity
10% owner
$1.00M (1)
$38.00M (7)
−$37.00M
8,494,572
—
$967.02M
−6.4%
Hendricks Diane
10% owner
$3.75M (1)
—
+$3.75M
4,091,724
60.96%
$465.80M
+11.6%
Leo Karl
10% owner
$1.25M (2)
—
+$1.25M
3,211,958
47.85%
$365.65M
+5.1%
Tsuchimoto Kim R
Director
$2.60K (1)
$811.74K (7) scheduled
−$809.14K
7,396
0.1102%
$841.96K
—
Robinson Chandler
Chief Executive Officer
—
$672.02K (1) scheduled
−$672.02K
4,606,689
68.63%
$524.43M
+8.5%
STARR CHRISTOPHER M
Director
—
$672.02K (1) scheduled
−$672.02K
202,773
3.02%
$23.08M
+14.6%
Anderson Raymond
Director
—
$351.19K (3) scheduled
−$351.19K
23,751
0.3538%
$2.70M
+2,206%
KLAUSNER ARTHUR J
Director
—
$343.89K (2)
−$343.89K
12,230,338
—
$1.39B
+0.2%
Cittadine Andrew
Chief Operating Officer
$149.66K (12)
—
+$149.66K
55,614
0.8286%
$6.33M
—
Vu Quan Anh
Chief Financial Officer
$104.93K (1)
—
+$104.93K
2,221
0.0331%
$252.84K
—
Radhakrishnan Karthik
Chief Financial Officer
$25.19K (1)
—
+$25.19K
1,550
0.0231%
$176.45K
—
RIOUX PATRICE
Acting Chief Medical Officer
—
$111.26 (1) scheduled
−$111.26
5,065
0.0755%
$576.60K
—
Brown Michael J
Director
—
—
—
9,083,410
—
$1.03B
+0.3%
Mazar Andrew Paul
Chief Scientific Officer
—
—
—
4,466,732
66.55%
$508.49M
+0.2%
TacticGem LLC entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Vu Quan Anh
26 Dec 2025
Chief Financial Officer
Buy
1,500
$69.95
$104.93K
Radhakrishnan Karthik
28 Oct 2024
Chief Financial Officer
Buy
1,550
$16.25
$25.19K
Cittadine Andrew
20 Jun 2024
Chief Operating Officer
Buy
20,508
$0.74
$15.25K
Cittadine Andrew
18 Jun 2024
Chief Operating Officer
Buy
12,000
$0.86
$10.32K
Cittadine Andrew
17 Jun 2024
Chief Operating Officer
Buy
12,000
$0.90
$10.80K
Cittadine Andrew
14 Jun 2024
Chief Operating Officer
Buy
12,000
$0.93
$11.18K
Cittadine Andrew
13 Jun 2024
Chief Operating Officer
Buy
12,000
$0.91
$10.92K
Cittadine Andrew
4 Jun 2024
Chief Operating Officer
Buy
12,000
$0.78
$9.36K
Cittadine Andrew
3 Jun 2024
Chief Operating Officer
Buy
12,000
$0.76
$9.12K
Cittadine Andrew
31 May 2024
Chief Operating Officer
Buy
12,000
$0.64
$7.73K
Cittadine Andrew
30 May 2024
Chief Operating Officer
Buy
12,000
$0.64
$7.68K
Cittadine Andrew
29 May 2024
Chief Operating Officer
Buy
12,000
$0.64
$7.64K
Cittadine Andrew
15 Nov 2022
Chief Operating Officer
Buy
10,000
$3.15
$31.50K
Cittadine Andrew
14 Nov 2022
Chief Operating Officer
Buy
6,053
$3.00
$18.16K
Tsuchimoto Kim R
18 Dec 2019
Chief Financial Officer
Buy
325
$8.00
$2.60K
Leo Karl
18 Dec 2019
10% owner
Buy
314
$8.00
$2.51K
Leo Karl
18 Dec 2019
10% owner
Buy indirect
156,250
$8.00
$1.25M
Tactic Pharma LLC
18 Dec 2019
10% owner
Buy
125,000
$8.00
$1.00M
Hendricks Diane
18 Dec 2019
10% owner
Buy indirect
468,750
$8.00
$3.75M
Show all 44 transactions →

What was left out

Form 4 filings counted 216
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 4
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 2,487,703
Sales filed before the plan box existed 5
History held since 27 Sep 2018